ViaLase

ViaLase

Private
Aliso Viejo, CaliforniaHealthcare & Life Scienceswww.vialase.com

Last Round

Series C

Apr 1, 2024

Total Funding Raised

$75.4M

Company Overview

ViaLase is a medical technology company that develops a laser surgical system for the non-invasive treatment of open-angle glaucoma using advanced optical coherence tomography (OCT) image-guided femtosecond laser technology to create customized drainage channels.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

glaucoma treatmentfemtosecond lasernoninvasive glaucoma treatmentimage-guided surgerytrabeculotomyFLigHTminimally invasive glaucoma surgeryMIGSprimary open-angle glaucomaPOAGophthalmologyglaucoma laserlaser trabeculotomymedical devicemedtechintraocular pressuresurgical laser

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ViaLase Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ViaLase Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CApr 1, 2024
SeedJan 18, 2024
Series ANov 1, 2021
SeedApr 1, 2019

Key People

Founding team and executive leadership

Tibor Juhasz

Chief Executive Officer

Executive Team

ViaLase Investors

Notable investors and investment history

InvestorRounds
Arboretum VenturesSeries C, Series A
Venture Investors Health FundSeries C
Venture Investors LLCSeed
Falcon VisionSeries C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2026

    Presenting new scientific research at the 2026 ARVO Annual Meeting.

  • Jan 18, 2024

    $2.3M raised in Seed round.

ViaLase Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ViaLase Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ViaLase's valuation, stock price, and market status.

Firmographic Details

HeadquartersAliso Viejo, California
Employee Range32
Year Founded2018
Last FundingApr 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.